School of Medicine
Showing 1-10 of 22 Results
-
Nicholas Antonios Kalogriopoulos
Postdoctoral Scholar, Genetics
BioNick's broad research interests are in developing tools and technologies for research and therapeutic applications. Nick obtained a B.S. in Genetics and Molecular Biology from the University of Wisconsin-Madison. During his undergraduate career, he trained with Dr. Paul Sondel, where he worked on preclinical testing of novel immunotherapeutic agents for the treatment of neuroblastoma. He obtained a Ph.D. in Biomedical Science with Dr. Pradipta Ghosh, elucidating the structural basis of non-canonical G protein activation by a novel protein family of Guanine Nucleotide Exchange Modulators (GEMs). As a Postdoctoral Researcher with Professor Alice Ting at Stanford University, his current research focuses on developing a new system for programmable and user-controlled cellular behaviors for immuno-oncology applications.
-
Peter William Earl Kane
co-Founder, Research to the People @ Stanford, Genetics
BioPeter is the co-Founder of Research to the People @ Stanford (https://rttp.stanford.edu).
Research to the People @ Stanford is a program for oncology patients who have exhausted their clinical options and need to move beyond standard of care. We generate advanced multi-omics data, run cutting edge analysis to interrogate new therapeutic possibilities.
We also lead discovery and AI innovation initiatives for complex multi-systemic disease.
Research to the People @ Stanford started with Fereshteh Jahanbani, PharmD, PhD at Stanford Medicine in July 2021. Michael Snyder, PhD (Dept. Chair, Genetics) was the sponsoring faculty member to make our program possible at Stanford Medicine. -
Maya M. Kasowski
Assistant Professor of Medicine (Sean N Parker Center for Allergy and Asthma Research) of Pathology and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
